Nuritas and Pharmavite partner on bioactive peptides in supplements
date:Jan 17, 2019
understandings of health are impacting how they may approach supplementation, for example, in 2019.

The partnership plans to leverage Nuritas technology platform, which combines AI and DNA analysis to predict, unlock and validate bioactive peptide ingredients. Pharmavite will deploy its experience to formulate the newly discovered bioactive peptides into consumer dose forms and validate the efficacy of these discoveries within clinical trials.

The initial phase of the project will involve Nur
3/9 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
07/07 22:28